The Race Is On: Biotech Beats Moore’s Law!

In 1965, one of the co-founder’s of Intel Corporation, Gordon E. Moore, wrote an article in Electronics Magazine on a trend he had been watching for several years in integrated circuit (chip) manufacturing.

Gordon observed that over the course of 18 months, the performance of computer chips manufactured had doubled in capability.  This phenomenon would later go on to be labeled “Moore’s Law” and has been a cornerstone for long-term planning within the semi-conductor industry since the 1960’s.

Now we can all attest to buying a new computer or smart phone, only to have something smaller, faster, and lighter come out in what seems like only days after your purchase.  But taking into consideration an 18-month cycle time on doubling of performance, how could this be?

What I’m about to say may fly in the face of reason but bear with me… recent breakthroughs in manufacturing technology and advanced computing have begun to surpass Moore’s Law.

What’s more is that it’s expected to be fully surpassed across the industry between 2015 and 2020 by constructing transistors at the atomic level.  That’s right!

In 2012, a research team from the University of New South Wales developed the first working transistor consisting of a single atom placed precisely on a silicon crystal.  Now it’s only a matter of time until production capability will ramp up across the industry because of this amazing breakthrough.

Many in biotech are starting to treat this breakthrough as an “enabling technology” for the industry as a whole.  Attacking hard problems such as sequencing a human genome for custom precision medicine. Ten years ago, it would have taken months to sequence a single genome, now this can be done in less than an hour.

IndieBio is a biotech startup company accelerator and they’re taking advantage of this new wave of technology by speeding up the business process of bringing newly enabled biotech solutions to market.

Ron Shigeta, the chief scientific officer of IndieBio recently stated: “What a lot of people seemed to have missed is that the pace of innovation in life sciences is accelerating, sequencing technologies alone are exceeding the pace of Moore’s law.”

Make no mistake, we are entering unchartered territory with these serious groundbreaking biotech innovations… all of which should make noticeable differences in how we live our lives over the next several years.

If you’re interested in learning more about game changing biotechnology and take advantage of market plays check out my Biotech Intel Trader service here.

As always, I’ll continue to monitor the market’s latest health and biotech technology trends via my social media collective intelligence tool and keep you updated on the latest.

Image Signature
Ben

Harry Dent’s Most Disturbing Prediction in Years

Harry Dent, one of the most respected economists in the industry, has uncovered a disturbing market event that could soon devastate millions of investors. In short, he has undeniable proof that one of the market’s safest and most popular investments is about to get slaughtered… and it will have dire consequences for those who don’t prepare right away.

For full details on the event Harry’s dubbed as the “Safe-Asset Slaughter”… and to ensure you escape the coming carnage, I urge you to watch this special presentation.

Click to Learn More
Categories: Biotech

About Author

Ben Benoy is a veteran of the U.S. Marine Corps and has been an active retail trader since 2006. He identifies investment opportunities based on key social media trends. He first identified the concept in 2008 and has since developed a tool for tracking investment “chatter” between social media users. His proprietary Social Media Stock Sentiment system has developed into a state-of-the-art platform that identifies and classifies chatter about stocks through algorithms and other indicators to forecast stock-price direction. Ben’s track record speaks for itself — over the past 12 months, his system boasts a win rate of 82.2% on 112 stock trades.